MWZ.MU
MetLife Inc
MunichEUREQUITY
DELAYED
Last price
80.44
▲ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
80.44
Prev close
80.44
Day high
0.00
Day low
0.00
Volume
0
Market cap
—
P/E (TTM)
—
52W range
0.00 – 86.09
Day trading desk
Gap from prior close
-2.05%
Prior close 82.12
VWAP
—
—
Relative volume
0.00×
Quiet session
Session range
—
80.44 – 80.44
Position in range
—
—
ATR (14D)
0.47
0.58% of price
Prior day high
82.12
PDH
Prior day low
82.12
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Avg 2
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-4.69%
-3.5%
1M
-1.36%
-4.7%
3M
+11.38%
+9.0%
6M
+20.44%
+8.6%
YTD
+17.59%
+5.6%
1Y
+18.40%
-1.7%
3Y
+40.07%
-34.9%
5Y
+55.11%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on MWZ.MU open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $75.65B | $70.13B | $67.93B | $67.41B | +7.9% |
| Operating revenue | $75.65B | $70.13B | $67.93B | $67.41B | +7.9% |
| Selling, general & admin | $6.28B | $5.99B | $6.18B | $5.86B | +4.8% |
| Net interest income | -$1.06B | -$1.04B | -$1.04B | -$938.00M | -2.3% |
| Pre-tax income | $4.66B | $5.62B | $2.16B | $6.36B | -17.1% |
| Tax provision | $1.26B | $1.18B | $560.00M | $1.06B | +6.8% |
| Net income | $3.38B | $4.43B | $1.58B | $5.28B | -23.7% |
| Net income to common | $3.17B | $4.23B | $1.38B | $5.10B | -24.9% |
| Basic EPS | 4.84 | 6.13 | 1.81 | 3.02 | -21.0% |
| Diluted EPS | 4.84 | 6.13 | 1.81 | 2.91 | -21.0% |
| EBIT | $5.72B | $6.66B | $3.21B | $7.30B | -14.1% |
| Basic shares | 655.33M | 689.21M | 762.43M | 779.10M | -4.9% |
| Diluted shares | 655.33M | 689.21M | 762.43M | 808.90M | -4.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $22.03B | $20.07B | $20.64B | $20.20B | +9.8% |
| Cash & short-term investments | $118.32B | $306.27B | $308.10B | $301.91B | -61.4% |
| Accounts receivable | $49.06B | $29.76B | $28.97B | $17.36B | +64.8% |
| Property, plant & equipment | $1.70B | $1.85B | $1.99B | $1.93B | -8.3% |
| Goodwill & intangibles | $9.61B | $8.90B | $9.24B | $9.30B | +8.0% |
| Total assets | $745.17B | $677.46B | $687.58B | $663.07B | +10.0% |
| Current debt | $1.56B | $465.00M | $119.00M | $175.00M | +235.7% |
| Long-term debt | $18.62B | $18.24B | $18.68B | $17.75B | +2.0% |
| Total debt | $20.18B | $18.71B | $18.83B | $17.98B | +7.8% |
| Total liabilities | $716.25B | $649.75B | $657.33B | $632.95B | +10.2% |
| Retained earnings | $44.29B | $42.63B | $40.15B | $40.33B | +3.9% |
| Shareholder equity | $28.40B | $27.45B | $30.02B | $29.88B | +3.5% |
| Net tangible assets | $18.79B | $18.54B | $20.78B | $20.58B | +1.3% |
| Shares issued | 1.20B | 1.19B | 1.19B | 1.19B | +0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $3.40B | $4.44B | $1.60B | $5.30B | -23.4% |
| Depreciation & amortisation | $753.00M | $714.00M | $718.00M | $673.00M | +5.5% |
| Change in working capital | $5.38B | $1.37B | $1.45B | $2.10B | +293.9% |
| Operating cash flow | $17.09B | $14.60B | $13.72B | $13.04B | +17.1% |
| Investing cash flow | -$15.61B | -$11.49B | -$10.25B | -$2.62B | -35.8% |
| Share buybacks | -$3.88B | -$3.21B | -$3.10B | -$3.33B | -21.1% |
| Dividends paid | -$1.70B | -$1.73B | -$1.76B | -$1.78B | +1.4% |
| Financing cash flow | $163.00M | -$3.13B | -$2.94B | -$9.95B | +105.2% |
| Free cash flow | $17.09B | $14.60B | $13.72B | $13.04B | +17.1% |
| End cash position | $22.03B | $20.07B | $20.64B | $20.20B | +9.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $18.88B | $18.62B | $23.29B | $16.88B | $17.18B | — | +1.4% |
| Operating revenue | $18.88B | $18.62B | $23.29B | $16.88B | $17.18B | — | +1.4% |
| Selling, general & admin | $1.69B | $1.70B | $1.64B | $1.53B | $1.54B | — | -0.6% |
| Net interest income | -$292.00M | -$265.00M | -$263.00M | -$271.00M | -$269.00M | — | -10.2% |
| Pre-tax income | $1.03B | $1.51B | $1.12B | $1.21B | $980.00M | — | -31.3% |
| Tax provision | $256.00M | $345.00M | $301.00M | $308.00M | $245.00M | — | -25.8% |
| Net income | $736.00M | $1.19B | $809.00M | $896.00M | $729.00M | — | -37.9% |
| Net income to common | $705.00M | $1.14B | $778.00M | $818.00M | $698.00M | — | -38.2% |
| Basic EPS | 1.10 | 1.75 | 1.18 | 1.23 | 1.04 | — | -37.3% |
| Diluted EPS | 1.10 | 1.74 | 1.17 | — | 1.03 | 1.28 | -36.9% |
| EBIT | $1.33B | $1.77B | $1.38B | $1.48B | $1.25B | — | -25.1% |
| Basic shares | 642.60M | 652.00M | 658.10M | — | 670.80M | 682.30M | -1.4% |
| Diluted shares | 646.90M | 655.70M | 662.20M | — | 675.00M | 687.00M | -1.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $19.30B | $22.69B | $22.03B | $20.23B | $22.18B | -14.9% |
| Cash & short-term investments | $122.04B | $120.62B | $118.32B | $114.77B | $112.69B | +1.2% |
| Accounts receivable | $50.63B | $50.34B | $49.06B | $40.33B | $31.50B | +0.6% |
| Property, plant & equipment | $1.64B | $1.59B | $1.70B | $1.62B | $1.82B | +3.2% |
| Goodwill & intangibles | $9.54B | $9.56B | $9.61B | $9.10B | $9.14B | -0.3% |
| Total assets | $759.37B | $743.21B | $745.17B | $719.73B | $702.47B | +2.2% |
| Current debt | $460.00M | $404.00M | $1.56B | $378.00M | $379.00M | +13.9% |
| Long-term debt | $20.89B | $20.73B | $18.62B | $19.45B | $19.53B | +0.8% |
| Total debt | $21.34B | $21.13B | $20.18B | $19.83B | $19.91B | +1.0% |
| Total liabilities | $731.41B | $715.41B | $716.25B | $690.53B | $674.54B | +2.2% |
| Retained earnings | $45.38B | $45.06B | $44.29B | $43.89B | $43.45B | +0.7% |
| Shareholder equity | $27.44B | $27.32B | $28.40B | $28.94B | $27.68B | +0.4% |
| Net tangible assets | $17.91B | $17.76B | $18.79B | $19.85B | $18.54B | +0.8% |
| Shares issued | 637.75M | 1.20B | 1.20B | 1.20B | 1.20B | -46.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Operating cash flow | $2.23B | $2.69B | $7.08B | $3.57B | $2.19B | -17.1% |
| Investing cash flow | -$8.87B | -$5.46B | -$4.29B | -$5.02B | -$2.98B | -62.6% |
| Share buybacks | -$722.00M | -$755.00M | -$460.00M | -$1.50B | -$510.00M | +4.4% |
| Dividends paid | -$414.00M | -$417.00M | -$406.00M | -$444.00M | -$413.00M | +0.7% |
| Financing cash flow | $3.22B | $3.56B | -$998.00M | -$508.00M | $1.45B | -9.6% |
| Free cash flow | $2.23B | $2.69B | $7.08B | $3.57B | $2.19B | -17.1% |
| End cash position | $19.30B | $22.69B | $22.03B | $20.23B | $22.18B | -14.9% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
83.67
-3.86% from price
SMA 20
83.85
-4.06% from price
SMA 50
80.47
-0.04% from price
SMA 100
74.13
+8.52% from price
SMA 200
69.69
+15.42% from price
EMA 12
83.22
-3.34% from price
EMA 26
82.61
-2.62% from price
EMA 50
80.24
+0.25% from price
RSI (14)
32.6
Neutral
MACD (12,26,9)
0.61
Hist -0.63
ATR (14)
0.47
0.58% of price
Realised vol 30D
12.2%
Annualised
Bollinger upper
85.96
20, 2σ
Bollinger lower
81.73
20, 2σ
50 / 200 cross
Golden
80.47 vs 69.69
Trend bias
Above 200
+15.42%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.07
Less volatile than market
Correlation to SPY
0.05
Largely independent
Realised vol 30D
12.2%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-16.4%
Peak to trough
Max drawdown 5Y
-38.9%
Peak to trough
ATR 14
0.47
0.58% of price
Beta (reported)
—
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 24, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| Aug 19, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Aug 11, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Aug 11, 26 | Keefe, Bruyette & Woods | MAINTAINED | Outperform | Outperform |
| Aug 6, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Jul 22, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Jul 21, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Jul 13, 26 | Evercore ISI Group | MAINTAINED | In-Line | In-Line |
| Jul 13, 26 | Keefe, Bruyette & Woods | MAINTAINED | Outperform | Outperform |
| Jul 10, 26 | Jefferies | MAINTAINED | Buy | Buy |
| Jul 9, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Jul 9, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
Headlines
Bank of America raises price targets on 10 software stocks
TheStreet · 8m ago
ICP DAS-BMP Brings Advanced Medical TPU Portfolio to Medical Manufacturing Asia 2026
PR Newswire · 10m ago
PDD (PDD) Q2 2026 Earnings Call Transcript
Motley Fool · 14m ago
Berkshire Hathaway Rose While Every Major Chip Stock Fell Monday
Motley Fool · 18m ago
Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules
GlobeNewswire · 19m ago
XP (XP) Q2 2026 Earnings Call Transcript
Motley Fool · 21m ago
Dow Jones Futures: Trump, Bessent Comments Spark Tech Losses; Nvidia Sells Off Before Earnings
Investor's Business Daily · 21m ago
SpaceX Raised $86 Billion and OpenAI Is Next. This ETF Owns the IPO Class of 2026
24/7 Wall St. · 22m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.